-
-
-
-
-
-
-
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025
-
-
-
-
-
-
-
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
-
-
-
-
-
-
-
Zai Lab Announces Full-Year 2023 Financial Results and Recent Corporate Updates
-
-
-
-
-
-
-
Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
-
-
-
-
-
-
-
Zai Lab Announces First Quarter 2022 Financial Results and Corporate Updates
-
-
-
-
-
-
-
Zai Lab and Novocure Announce Last Patient Enrolled in Phase 2 Pilot Trial of Tumor Treating Fields Plus Chemotherapy as First-Line Treatment in Gastric Cancer in China
-
-
-
-
-
-
-
Zai Lab Announces Financial Results for Second-half and Full-year 2020
-
1,208,463 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

